Clinical Outcome of Residual Liver Volume and Hepatic Steatosis After Right-Lobe Living-Donor Hepatectomy.
CONCLUSIONS Hyperbilirubinemia was a risk factor in the small-RLV group, and a large amount of pleural effusion was a risk factor in the steatosis 30-50% group. Hepatic steatosis subgroups did not show significantly different degrees of regeneration. The safety of living donors was a major concern while we compiled the extended living-donor criteria presented in this paper.
PMID: 32152262 [PubMed - in process]
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Hsieh CE, Lin KH, Hsu YL, Chou CT, Chen CB, Lin PY, Lin CC, Hung YJ, Weng LC, Chen YL Tags: Ann Transplant Source Type: research
More News: Bilirubin | Liver | Liver Transplant | Transplant Surgery | Transplants | Urology & Nephrology